Versigent (NYSE:VGNT) Upgraded at Zacks Research

Zacks Research upgraded shares of Versigent (NYSE:VGNT) to a hold rating in a research report report published on Thursday morning,Zacks.com reports.

Several other equities analysts have also recently commented on the stock. Wall Street Zen raised shares of Versigent to a “hold” rating in a research report on Saturday. Fox Advisors raised shares of Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. UBS Group started coverage on shares of Versigent in a research report on Tuesday. They set a “buy” rating and a $43.00 target price on the stock. Royal Bank Of Canada initiated coverage on shares of Versigent in a research report on Tuesday, March 31st. They set a “sector perform” rating and a $28.00 target price on the stock. Finally, TD Cowen initiated coverage on shares of Versigent in a report on Tuesday. They issued a “buy” rating and a $47.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Versigent currently has a consensus rating of “Moderate Buy” and an average target price of $38.25.

Versigent Trading Up 6.4%

Versigent stock opened at $34.69 on Thursday. Versigent has a 52 week low of $26.34 and a 52 week high of $35.08.